12269University of Minnesota Medical School, Minneapolis, MN, USA.
Division of Child Neurology, 14676University of Colorado, Colorado Springs, CO, USA.
J Child Neurol. 2021 Feb;36(2):123-127. doi: 10.1177/0883073820954617. Epub 2020 Sep 15.
Secondary narcolepsy occurs as a consequence of lesions involving the hypothalamic region that subserve wakefulness. Although observations on the characteristics of secondary narcolepsy have been published in adults, information on this topic in children is sparse. This is a retrospective study of characteristics and outcome of secondary narcolepsy in children. The medical records of 10 children with this condition at Mayo Clinic, Rochester, were reviewed. Characteristics of the underlying neurologic disorder, narcolepsy subtype, multiple sleep latency tests, medications used and outcome were extracted. Age at diagnosis of narcolepsy was between 6 and 17 years. Five of 10 patients had onset of excessive sleepiness within 1 year of diagnosis of the primary neurologic disorder. Six of 10 patients had type 1 narcolepsy (with cataplexy) whereas 4/10 had type 2 (without cataplexy). The clinical course was variable, with 8/10 continuing to require treatment for sleepiness at a mean period 6.6±6.2 years after diagnosis. One patient with narcolepsy type 1 due to Niemann Pick type C disease had died. One patient with narcolepsy type 2 due to craniopharyngioma had spontaneous remission of sleepiness. The 5/10 patients surviving with narcolepsy type 1 have continued to require pharmacotherapy for both sleepiness and cataplexy. This study draws attention to an important chronic sequel of childhood brain lesions that has variable, etiology-specific outcome. The rare occurrence of spontaneous resolution of childhood narcolepsy symptoms, not previously described, is also discussed.
继发性嗜睡症是由于下丘脑区域的病变导致的,这些病变会影响清醒状态。虽然成年人继发性嗜睡症的特征已经有观察报道,但儿童中关于这个主题的信息很少。这是一项关于儿童继发性嗜睡症特征和结局的回顾性研究。对罗切斯特梅奥诊所的 10 名患有这种疾病的儿童的病历进行了回顾。提取了潜在神经障碍、嗜睡症亚型、多次睡眠潜伏期试验、使用的药物和结局的特征。嗜睡症的诊断年龄在 6 至 17 岁之间。10 名患者中有 5 名在原发性神经障碍诊断后 1 年内出现过度嗜睡。10 名患者中有 6 名患有 1 型嗜睡症(伴猝倒),而 4 名患有 2 型(不伴猝倒)。病程各异,8/10 名患者在诊断后平均 6.6±6.2 年仍需要治疗睡眠。1 名患有尼曼-匹克 C 型病的 1 型嗜睡症患者死亡。1 名患有颅咽管瘤的 2 型嗜睡症患者自发性缓解了嗜睡。5/10 名存活的 1 型嗜睡症患者仍需要药物治疗来缓解嗜睡和猝倒。本研究提请注意儿童脑损伤的一个重要慢性后果,其具有可变的、病因特异性的结局。此外,还讨论了以前未描述过的儿童嗜睡症症状自发缓解的罕见情况。